McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

by McKesson Ventures | Apr 8, 2024 | Press Releases

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...

Recent Posts

  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
  • Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
  • BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
  • Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings